• Home
  • NEW DAY MEDICINE
  • 12 (74) 2024
  • 105 -12 (74) 2024 - Ormanov T.N., Allayeva M.J. - THE EFFECT OF LYSOZYME AND GLYCINE-FIXED HIRUDOTHERAPY ON MURAMIDASE ACTIVITY OF ORAL FLUID IN PATIENTS WITH POSTCOVID SYNDROME DEPENDING ON SENSITIVITY TO XE

105 -12 (74) 2024 - Ormanov T.N., Allayeva M.J. - THE EFFECT OF LYSOZYME AND GLYCINE-FIXED HIRUDOTHERAPY ON MURAMIDASE ACTIVITY OF ORAL FLUID IN PATIENTS WITH POSTCOVID SYNDROME DEPENDING ON SENSITIVITY TO XE

THE EFFECT OF LYSOZYME AND GLYCINE-FIXED HIRUDOTHERAPY ON MURAMIDASE ACTIVITY OF ORAL FLUID IN PATIENTS WITH POSTCOVID SYNDROME DEPENDING ON SENSITIVITY TO XENOBIOTICS

Ormanov T.N. - International Kazakh-Turkish University named after Khoja Ahmed Yasawi Kazakhstan, Turkestan

Allayeva M.J. - Tashkent Medical Academy (TMA) Uzbekistan

Ormanov N.J. - South Kazakhstan Medical Academy Shymkent

Zhakipbekova G.S. - South Kazakhstan Medical Academy Shymkent

Ishigov I.A. - International Kazakh-Turkish University named after Khoja Ahmed Yasawi Kazakhstan, Turkestan

Resume

Depression of the lysozyme status of oral fluid (OJ) was found in postcovid syndrome, muramidase activity in resistant, sensitive, very sensitive patients was reduced by 20.5%, 30.3% and 42.0%. The certified Medical Leech (MP) restored the muramidase status of the oral fluid of resistant, sensitive and very sensitive patients after the 9th, 15th and 21st procedures. Fixed lysozyme and glycine MP induces muramidase activity of oral genesis in resistant, sensitive and very sensitive patients by 25.0%, 28.5% and 31.7% and reaches the value of healthy individuals after 1.2 and 4 times the procedure. The course dose of certified and fixed medical leech in resistant sensitive and highly sensitive patients with PKS in traditional hirudotherapy was 60.0 g,150.0 g and 210.0 g, and with fixed hirudotherapy -10.0 g,40.0 g and 90.0 g.

Key words: Postcovoid syndrome.Certified and fixed with lysozyme and glycine (original) hirudotherapy. Muramidase status of oral genesis

First page

547

Last page

553

For citation:Ormanov T.N., Allayeva M.J., Ormanov N.J., Zhakipbekova G.S., Ishigov I.A. - THE EFFECT OF LYSOZYME AND GLYCINE-FIXED HIRUDOTHERAPY ON MURAMIDASE ACTIVITY OF ORAL FLUID IN PATIENTS WITH POSTCOVID SYNDROME DEPENDING ON SENSITIVITY TO XENOBIOTICS//New Day in Medicine 12(74)2024 547-553 https://https://newdayworldmedicine.com/en/new_day_medicine/12-74-2024

List of References

  1. Лизоцим: теория и практика / А. А. Баранов, В. Г. Дорофейчук; Союз педиатров России, Нижегор. НИИ дет. гастроэнтерологии МЗ России. - Москва; Н. Новгород, 1999; - 126 с.: ил.; 20 см.; ISBN 5-900818-36-5
  2. Дорофейчук В.Г. Механизм защитной функции лизоцима: фундаментальное и прикладное знание. //Нижегородский мед. журнал 1996;2:9-13.
  3. Калюжин О.В. Антибактериальные, противогрибковые, противовирусные и иммуномодулирующие эффекты лизоцима: от механизмов к фармакологическому применению. Эффективная фармакотерапия. 2018;1(14):6-13. Режим доступа: https://umedp.ru/articles/antibakterialnye _proti-vogribkovye protivovirusnyei_ immunomoduliruyushchie_ effekty_ lizotsima_ ot _mekh. Html.
  4. Serikbayeva Saltanat Zh., Ashirova M.Z., Ormanov N.Zh., Ormanov T.N., Abuova G.N., and Kaishibayeva Gulnaz S. (2023). Peroxidation Of Saliva Lipids In Patients With Postcovid Syndrome During Hirudotherapy. //Journal of Population Therapeutics and Clinical Pharmacology, 2023;30(11):400-404. https://doi.org/10.47750 / jptcp.2023.30.11.041.
  5. Saltanat Serikbayeva, Namazbay Ormanov, Talgat Ormanov, Ibragim Ishigov, Murat Zhunussov, Gulnaz Kayshibayeva, Ferruh Yücel. Rehabilitation of COVID-19 patients with cognitive, autonomic and sleep disorders using medicinal leech therapy. //Journal of Integrative and Anatolian Medicine. //Bütünleyici Ve Anadolu Tıbbı Dergisi, 2023(4):3-20. https://doi.org/10.53445/batd.1277497.
  6. Serikbayeva Saltanat, Shaimerdenova Gulbanu, Оrmanov Namazbai, Оrmanov Тalgat, Аbuova Gulzhan, Kaishibayeva Gulnaz, Kemelbekov Kanatzhan. Peroxidation of saliva lipids in patients with postcovid syndrome during hirudotherapy. //Georgian medical news 2024;7-8(352-353):265-269.
  7. Григорьева А.А., Румянцев Е.К., Николаев В.М. и др. Перекисное окисление липидов в развитии некоторых симптомов постковидного синдрома //Якутский медицинский журнал. 2022;1(77):83-86. DOI:10.25789/YMJ.2022.77.19
  8. Баскова И.П., Харитонова О.В., Завалова Л.Л. (2011). Лизоцимная активность секрета слюнных желез медицинской пиявки видов: h. verbana, h. medicinalis и h. orientalis. //Биомедицинская химия 2011;57(5):511-518.
  9. Адильбекова Д.А., Орманов Н.Ж. Способ определения индивидуальной восприимчивости организма к желтому фосфору. /Патент РК № 2006 / 0639.1 от 25.09.2008 г.
  10. Матвеевская Н.С. Способ автоматизированного определения концентрации активного лизоцима в биологических образцах. /Российский патент 2024 года по МПК C12Q1/02 C12N9/36 G01N33/48, Опубликовано: 03.06.2024. Бюл. № 16.

    file

    download